Femasys (FEMY) News Today $0.71 -0.03 (-4.35%) Closing price 08/15/2025 04:00 PM EasternExtended Trading$0.73 +0.02 (+3.22%) As of 08/15/2025 07:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock FEMY Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period HC Wainwright Analysts Raise Earnings Estimates for FemasysAugust 16 at 3:03 AM | americanbankingnews.comHC Wainwright Lowers Femasys (NASDAQ:FEMY) Price Target to $8.00August 13 at 2:37 AM | americanbankingnews.comFemasys Enters European Market with Major Spain OrderAugust 12, 2025 | theglobeandmail.comFemasys Inc.: Femasys Announces Second Quarter Financial Results for 2025August 9, 2025 | finanznachrichten.deFemasys Revenue Jumps 85 Percent in Q2August 8, 2025 | fool.comFemasys Announces Second Quarter Financial Results for 2025August 8, 2025 | globenewswire.comFemasys Secures First European Order for FemBloc, Marking Strategic Milestone in Global ExpansionAugust 6, 2025 | globenewswire.comFemasys Inc. (FEMY) Latest Stock News & Headlines - Yahoo FinanceJuly 11, 2025 | finance.yahoo.comFemasys Enters Purchase Agreement with Alumni CapitalJuly 3, 2025 | tipranks.comFemasys Gains Regulatory Approvals in Australia and New ZealandJuly 1, 2025 | tipranks.comFemasys Achieves Australian and New Zealand Regulatory Approvals for FemaSeed® for First-Line Infertility Treatment and FemVue DiagnosticJuly 1, 2025 | globenewswire.comFemasys Inc. Receives CE Mark Certification for Revolutionary FemBloc® System for Non-Surgical Permanent Birth Control - NasdaqJune 27, 2025 | nasdaq.comFemasys Gains European Approval for FemBloc SystemJune 26, 2025 | msn.comFemasys Approves Director Elections and Share IncreaseJune 25, 2025 | tipranks.comFemasys Announces Historic Milestone with European Approval of FemBloc®, the First Non-Surgical Permanent Birth ControlJune 25, 2025 | globenewswire.comFemasys Appoints Kelley Nicholas as Chief Commercial OfficerJune 17, 2025 | tipranks.comFemasys Names New Chief Commercial Officer to Drive Execution and Global GrowthJune 17, 2025 | globenewswire.comFemasys Partners with Carolinas Fertility Institute to Enhance Access to FemaSeed® as First-Line Infertility TreatmentJune 13, 2025 | nasdaq.comThe Analyst Verdict: Femasys In The Eyes Of 6 ExpertsJune 11, 2025 | benzinga.comFemasys Announces Partnership with Carolinas Fertility Institute, One of America's Best Fertility Clinics, to Offer FemaSeed® in its More than 8 LocationsJune 11, 2025 | globenewswire.comFemasys Announces $4.5 Mln Offering Through Public Sale And Private Placement Of SharesJune 1, 2025 | nasdaq.comFemasys Announces Pricing of Underwritten Public Offering and Concurrent Private Placement with Gross Proceeds of $4.5 MillionMay 30, 2025 | finance.yahoo.comFemasys Stock Slides After Company Prices Public Offering At Discount: Retail’s Planning To Load UpMay 30, 2025 | msn.comFemasys Announces Proposed Public Offering of Common Stock and Concurrent Private PlacementMay 29, 2025 | globenewswire.comFemasys faces potential delisting from NasdaqMay 24, 2025 | uk.investing.com7FEMY : Analyst Expectations For Femasys's FutureMay 9, 2025 | benzinga.comFemasys Announces Financial Results for Quarter Ended March 31, 2025, and Provides Corporate UpdateMay 8, 2025 | globenewswire.comFemasys reports FY24 EPS (85c), consensus (81c)March 28, 2025 | markets.businessinsider.comFemasys Reports Wider-Than-Expected Annual Loss, But Retail Continues To Be OptimisticMarch 27, 2025 | msn.comFemasys Announces Financial Results for Year Ended December 31, 2024, and Provides Corporate UpdateMarch 27, 2025 | globenewswire.comFemasys enters partnership with CNY FertilityMarch 21, 2025 | markets.businessinsider.comFemasys price target raised to $15 from $12 at H.C. WainwrightMarch 20, 2025 | markets.businessinsider.comFemasys Announces Partnership with CNY Fertility, National Conglomerate Network of Fertility Centers, to Offer FemaSeed in its 11 LocationsMarch 19, 2025 | globenewswire.comFemasys secures partnerships for commercialization of FemBloc in SpainMarch 18, 2025 | markets.businessinsider.comAssessing Femasys: Insights From 4 Financial AnalystsMarch 18, 2025 | benzinga.comFemasys Secures Distribution Partnerships for Commercialization of FemBloc® in SpainMarch 18, 2025 | globenewswire.comFemasys announces FemBloc delivery system approval in EuropeMarch 14, 2025 | markets.businessinsider.comFemasys Announces FemBloc Delivery System Approval in Europe; A Significant Step Towards FemBloc Permanent Birth Control Availability as the First-Ever Non-Surgical ApproachMarch 13, 2025 | globenewswire.comFemasys Inc.: Femasys Announces Peer-Reviewed Publication of Positive Safety and Efficacy Results from FemBloc Permanent Birth Control Clinical TrialsFebruary 25, 2025 | finanznachrichten.deFemasys announces publication of ‘positive’ results from FemBloc trialsFebruary 25, 2025 | markets.businessinsider.comFemasys Announces Peer-Reviewed Publication of Positive Safety and Efficacy Results from FemBloc® Permanent Birth Control Clinical TrialsFebruary 25, 2025 | globenewswire.comFemasys gains UK approval for women's health productsFebruary 11, 2025 | msn.comAnalysts Are Bullish on Top Healthcare Stocks: DENTSPLY SIRONA (XRAY), Femasys (FEMY)February 11, 2025 | markets.businessinsider.comFemasys Announces UK Regulatory Approvals for FemaSeed® for Female Infertility Treatment and Two Diagnostic DevicesFebruary 11, 2025 | globenewswire.comFemasys Inc.: Femasys Announces Israeli Regulatory Approvals for FemaSeed for Female Infertility Treatment and Two Diagnostic DevicesFebruary 4, 2025 | finanznachrichten.deFemasys announces Israeli regulatory approvals for FemaSeed treatmentFebruary 4, 2025 | markets.businessinsider.comFemasys Announces Israeli Regulatory Approvals for FemaSeed® for Female Infertility Treatment and Two Diagnostic DevicesFebruary 4, 2025 | finance.yahoo.comFemasys announces notices of intention to grant 2 European patent applicationsJanuary 31, 2025 | markets.businessinsider.comFemasys Inc.: Femasys Announces Notices of Intention to Grant for Two New European Patent Applications Covering Use of FemBloc Permanent Birth ControlJanuary 30, 2025 | finanznachrichten.deFemasys Announces Notices of Intention to Grant for Two New European Patent Applications Covering Use of FemBloc Permanent Birth ControlJanuary 30, 2025 | globenewswire.com Get Femasys News Delivered to You Automatically Sign up to receive the latest news and ratings for FEMY and its competitors with MarketBeat's FREE daily newsletter. Email Address FEMY Media Mentions By Week FEMY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FEMY News Sentiment▼0.250.62▲Average Medical News Sentiment FEMY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FEMY Articles This Week▼101▲FEMY Articles Average Week Get Femasys News Delivered to You Automatically Sign up to receive the latest news and ratings for FEMY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Soleno Therapeutics News Microbot Medical News Avita Medical News Lucid Diagnostics News InspireMD News icad News Orchestra BioMed News Jin Medical International News Fonar News Hyperfine News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:FEMY) was last updated on 8/16/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored"I'm risking my reputation on this"A massive supply shock is building in the crypto market that could send Bitcoin to $300,000 this year. That...Crypto 101 Media | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Femasys Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Femasys With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access